BIO vs SNX · rev $651.0M vs P/E 16, rev $19.57B
BIO (BIO) versus Synnex Corporation (SNX) — a side-by-side from cached financials, not a winner call.
BIO (BIO) common stock.
Synnex Corporation (SNX) is a electronics & computer distribution company listed on US.
Latest reported BIO revenue for 2026-06-30 was $651.0M. Net income was $371.4M. Revenue was up 9.9% from 2026-03-31 to 2026-06-30. BIO currently screens at market cap $0.
Latest reported SNX revenue for 2026-05-31 was $19.57B. Net income was $334.1M. Revenue was up 14.1% from 2026-02-28 to 2026-05-31. SNX currently screens at market cap $11.13B and trailing P/E 15.9.
BIO currently screens at market cap $0. SNX currently screens at market cap $11.13B and trailing P/E 15.9.
Not investment advice. Open the BIO and SNX stock pages for the full models.
Not investment advice.